Cargando…

Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19

PURPOSE: Following a severe COVID-19 infection, a proportion of individuals develop prolonged symptoms. We investigated the immunological dysfunction that underlies the persistence of symptoms months after the resolution of acute COVID-19. METHODS: We analyzed cytokines, cell phenotypes, SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hocini, Hakim, Wiedemann, Aurélie, Blengio, Fabiola, Lefebvre, Cécile, Cervantes-Gonzalez, Minerva, Foucat, Emile, Tisserand, Pascaline, Surenaud, Mathieu, Coléon, Séverin, Prague, Mélanie, Guillaumat, Lydia, Krief, Corinne, Fenwick, Craig, Laouénan, Cédric, Bouadma, Lila, Ghosn, Jade, Pantaleo, Giuseppe, Thiébaut, Rodolphe, Lévy, Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029801/ https://www.ncbi.nlm.nih.gov/pubmed/36943669 http://dx.doi.org/10.1007/s10875-023-01459-x

Ejemplares similares

Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19
por: Hocini, Hakim, et al.
Publicado: (2023)

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
por: Lévy, Yves, et al.
Publicado: (2021)

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
por: Lévy, Yves, et al.
Publicado: (2022)

Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome
por: Bouadma, Lila, et al.
Publicado: (2020)

P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ART
por: Menkova-Garnier, Inna, et al.
Publicado: (2016)

Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
por: Coléon, Séverin, et al.
Publicado: (2022)

Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
por: Marlin, Romain, et al.
Publicado: (2021)

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial
por: Lévy, Y., et al.
Publicado: (2021)

Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
por: Alexandre, Marie, et al.
Publicado: (2022)

A novel approach for biomarker selection and the integration of repeated measures experiments from two assays
por: Liquet, Benoit, et al.
Publicado: (2012)

Long-lasting severe immune dysfunction in Ebola virus disease survivors
por: Wiedemann, Aurélie, et al.
Publicado: (2020)

Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?
por: Prague, Mélanie, et al.
Publicado: (2022)

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients
por: Wiedemann, Aurélie, et al.
Publicado: (2022)

Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells
por: Surenaud, Mathieu, et al.
Publicado: (2016)

Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
por: Alexandre, Marie, et al.
Publicado: (2023)

The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients
por: Perreau, Matthieu, et al.
Publicado: (2021)

Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
por: Thiébaut, Rodolphe, et al.
Publicado: (2019)

Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation
por: Pasin, Chloé, et al.
Publicado: (2019)

Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2
por: Clairon, Quentin, et al.
Publicado: (2023)

Decreased HIV-Specific T-Regulatory Responses Are Associated with Effective DC-Vaccine Induced Immunity
por: Brezar, Vedran, et al.
Publicado: (2015)

Impact of non-pharmaceutical interventions, weather, vaccination, and variants on COVID-19 transmission across departments in France
por: Paireau, Juliette, et al.
Publicado: (2023)

Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

What procalcitonin brings to management of sepsis in the ICU
por: Wolff, Michel, et al.
Publicado: (2010)

Quantifying and Predicting the Effect of Exogenous Interleukin-7 on CD4(+)T Cells in HIV-1 Infection
por: Thiébaut, Rodolphe, et al.
Publicado: (2014)

Artificial Intelligence in Public Health and Epidemiology
por: Thiébaut, Rodolphe, et al.
Publicado: (2018)

Artificial Intelligence for Surveillance in Public Health
por: Thiébaut, Rodolphe, et al.
Publicado: (2019)

Public Health and Epidemiology Informatics: Recent Research Trends Moving toward Public Health Data Science
por: Cossin, Sébastien, et al.
Publicado: (2020)

Convalescents
Publicado: (1907)

Convalescence
Publicado: (1875)

Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study
por: Bodez, Diane, et al.
Publicado: (2016)

Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
por: Lévy, Yves, et al.
Publicado: (2020)

Herrera y Reissig : del modernismo a la vanguardia
por: Blengio Brito, Raúl
Publicado: (1978)

ZnT8-Specific CD4(+) T Cells Display Distinct Cytokine Expression Profiles between Type 1 Diabetes Patients and Healthy Adults
por: Chujo, Daisuke, et al.
Publicado: (2013)

Management of neurological complications of infective endocarditis in ICU patients
por: Sonneville, Romain, et al.
Publicado: (2011)

A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma
por: Fenwick, Craig, et al.
Publicado: (2021)

Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort
por: Ghosn, Jade, et al.
Publicado: (2021)

Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
por: Crescenzo-Chaigne, Bernadette, et al.
Publicado: (2021)

Surgical Convalescence
por: Siegel, John H.
Publicado: (1959)

Convalescent Homes
Publicado: (1905)

Cannot write session to /tmp/vufind_sessions/sess_ri7ekk54sqeput867b9eerdaif